Brain+ publishes its Annual Report for 2023 – A year of market access, product development and a refocused commercial strategy
Copenhagen, Denmark, April 28, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+”), a company pioneering health tech solutions for better dementia management, today published its Annual Report for 2023. The report emphasizes the company’s financial and business performance during the reporting year and its outlook and objectives for 2024. To secure the necessary funding for the company’s continued business activities and the execution of its UK focused commercial plan, Brain+ earlier today announced a partially secured unit rights issue of up to DKK 8.9 million with